158 related articles for article (PubMed ID: 3220052)
1. A case of Graves' disease associated with an autonomously functioning thyroid nodule (AFTN) (Marine-Lenhalt syndrome) which spontaneously became a cold nodule.
Konno N; Hirokawa J; Abe S
Endocrinol Jpn; 1988 Oct; 35(5):753-8. PubMed ID: 3220052
[TBL] [Abstract][Full Text] [Related]
2. Coexistence of an autonomously functioning thyroid nodule in a patient with Graves' disease: an unusual presentation of Marine-Lenhart syndrome.
Nishikawa M; Yoshimura M; Yoshikawa N; Toyoda N; Yonemoto T; Ogawa Y; Mori S; Tabata S; Tokoro T; Sakaguchi N; Inada M
Endocr J; 1997 Aug; 44(4):571-4. PubMed ID: 9447292
[TBL] [Abstract][Full Text] [Related]
3. An uncommon case of Marine-Lenhart syndrome.
Giuffrida G; Giovinazzo S; Certo R; Vicchio TM; Baldari S; Campennì A; Ruggeri RM
Arq Bras Endocrinol Metabol; 2014 Jun; 58(4):398-401. PubMed ID: 24936736
[TBL] [Abstract][Full Text] [Related]
4. The development of a solitary toxic thyroid nodule following Graves' disease.
Ikekubo K; Hino M; Ito H; Otani M; Shimozato S; Nasu K; Habuchi Y; Yamaguchi H; Saiki Y; Ishihara T
Clin Nucl Med; 1988 Oct; 13(10):748-50. PubMed ID: 2846224
[TBL] [Abstract][Full Text] [Related]
5. Graves' disease with an autonomously functioning thyroid nodule: case report.
Jabrocka-Hybel A; Gołkowski F; Bałdys-Waligórska A; Sokołowski G; Hubalewska-Dydejczyk A
Pol Arch Med Wewn; 2009; 119(7-8):505-8. PubMed ID: 19776692
[TBL] [Abstract][Full Text] [Related]
6. Onset of Marine-Lenhart syndrome and Graves' ophthalmopathy in a female patient treated with alemtuzumab for multiple sclerosis.
Le Moli R; Russo M; Malandrino P; Vella V; Belfiore A; Frasca F
Hormones (Athens); 2021 Mar; 20(1):161-165. PubMed ID: 32500462
[TBL] [Abstract][Full Text] [Related]
7. Thyroid nodules in Graves' disease: classification, characterization, and response to treatment.
Carnell NE; Valente WA
Thyroid; 1998 Aug; 8(8):647-52. PubMed ID: 9737358
[TBL] [Abstract][Full Text] [Related]
8. Thyroid nodules in Graves' disease: classification, characterization, and response to treatment.
Carnell NE; Valente WA
Thyroid; 1998 Jul; 8(7):571-6. PubMed ID: 9709909
[TBL] [Abstract][Full Text] [Related]
9. A patient with an autonomously functioning thyroid nodule with papillary adenocarcinoma associated with Graves' hyperthyroidism.
Tsuboi M; Shigemasa C; Ueta Y; Yoshida A; Kobayashi K; Mori T; Mashiba H
Clin Nucl Med; 1995 Nov; 20(11):985-8. PubMed ID: 8565381
[TBL] [Abstract][Full Text] [Related]
10. Analysis of human sodium/iodide symporter, thyroid transcription factor-1, and paired-box-protein-8 gene expression in benign thyroid diseases.
Joba W; Spitzweg C; Schriever K; Heufelder AE
Thyroid; 1999 May; 9(5):455-66. PubMed ID: 10365677
[TBL] [Abstract][Full Text] [Related]
11. Marine-Lenhart syndrome with papillary thyroid carcinoma.
Atmaca H; Çolak R; Yazici ZA; Kefeli M; Tosun FC
J Res Med Sci; 2015 Apr; 20(4):412-5. PubMed ID: 26110000
[TBL] [Abstract][Full Text] [Related]
12. Sequential presentation of a case of hyperthyroidism with autonomously functioning nodules and Graves' disease in the presence of IgG thyroid stimulators.
Smyth PP; Neylan D; McMullan NM; Smith DF; McKenna TJ
Acta Endocrinol (Copenh); 1988 Aug; 118(4):474-8. PubMed ID: 2899938
[TBL] [Abstract][Full Text] [Related]
13. Marine-Lenhart syndrome in a young girl.
Şen Y; Cimbek EA; Yuca SA; Gedik GK; Sarı O
J Pediatr Endocrinol Metab; 2014 Jan; 27(1-2):189-91. PubMed ID: 24057592
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of surgical management of hyperthyroidism: 15-year experience from a tertiary care center in a developing country.
Pradeep PV; Agarwal A; Baxi M; Agarwal G; Gupta SK; Mishra SK
World J Surg; 2007 Feb; 31(2):306-12; discussion 313. PubMed ID: 17219271
[TBL] [Abstract][Full Text] [Related]
15. Toxic adenoma and papillary thyroid carcinoma in a patient with Graves' disease.
Valenti TM; Macchia E; Pisa R; Bucalo ML; Russo V; Colletti I; Compagno V; Abbadi V; Donatelli M
J Endocrinol Invest; 1999 Oct; 22(9):701-4. PubMed ID: 10595835
[TBL] [Abstract][Full Text] [Related]
16. Thyroid nodules in Graves' disease: implications in an endemically iodine deficient area.
Mishra A; Mishra SK
J Postgrad Med; 2001; 47(4):244-7. PubMed ID: 11832639
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and management of the autonomously functioning thyroid nodule: the Walter Reed Army Medical Center experience, 1975-1996.
Burch HB; Shakir F; Fitzsimmons TR; Jaques DP; Shriver CD
Thyroid; 1998 Oct; 8(10):871-80. PubMed ID: 9827653
[TBL] [Abstract][Full Text] [Related]
18. Appearance of Graves'-like disease following regression of autonomously functioning thyroid nodules. Two case reports.
Orsolon P; Lupi A; De Antoni Migliorati G; Vianello Dri A
Minerva Endocrinol; 1998 Jun; 23(2):53-6. PubMed ID: 9844355
[TBL] [Abstract][Full Text] [Related]
19. Subclinical Graves' disease as a cause of subnormal TSH levels in euthyroid subjects.
Kasagi K; Takeuchi R; Misaki T; Kousaka T; Miyamoto S; Iida Y; Konishi J
J Endocrinol Invest; 1997 Apr; 20(4):183-8. PubMed ID: 9211123
[TBL] [Abstract][Full Text] [Related]
20. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma.
Pacini F; Fontanelli M; Fugazzola L; Elisei R; Romei C; Di Coscio G; Miccoli P; Pinchera A
J Clin Endocrinol Metab; 1994 Apr; 78(4):826-9. PubMed ID: 8157706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
